[PDF][PDF] 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the …

…, SL Bridges Jr, WW Chatham, HE Paulus… - Arthritis care & …, 2012 - Wiley Online Library
The American College of Rheumatology (ACR) most recently published recommendations
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis

…, C Finney, JR Curtis, HE Paulus… - Arthritis Care & …, 2008 - Wiley Online Library
Paulus has received consultant fees (less than $10,000 each) from Amgen, Roche and
Mathematica. Dr. Chatham has received speaking fees and honoraria (less than $10,000 each) …

A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early …

LW Moreland, JR O'Dell, HE Paulus… - Arthritis & …, 2012 - Wiley Online Library
… Matching placebos were used throughout the trial, including during the step-up period,
when all participants were dispensed a step-up kit even if he or she was already receiving …

Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons.

…, DA Hardman, HE Paulus - Proceedings of the …, 1980 - National Acad Sciences
Low density lipoproteins and the triglyceride-rich lipoproteins of human serum each contain
proteins of high molecular weight termed apolipoprotein B, which have previously been …

Immunosuppressive and corticosteroid therapy of polyarteritis nodosa

ES Leib, C Restivo, HE Paulus - The American journal of medicine, 1979 - Elsevier
The clinical manifestations, treatment and survival of 64 patients with polyarteritis nodosa
seen from 1955 to 1977 were evaluated. In general, the patients had multisystem involvement. …

Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid …

…, DE Furst, ME Weinblatt, EC Keystone, HE Paulus… - Clinical …, 2003 - Elsevier
Background: Because traditional therapies for rheumatoid arthritis (RA) such as methotrexate
(MTX) do not produce an adequate response in many patients, newer therapies that block …

Comparison of naproxen and acetaminophen in a two‐year study of treatment of osteoarthritis of the knee

…, GS Alarcón, RF Willkens, HE Paulus… - … : Official Journal of …, 1993 - Wiley Online Library
Objective. To compare the relative safety and efficacy of naproxen and acetaminophen in
the treatment of osteoarthritis (OA) of the knee. The major outcome measures were …

[PDF][PDF] ACR remission criteria and response criteria

…, D Khanna, HE Paulus - Clinical and experimental …, 2006 - clinexprheumatol.org
As additional DMARDs have been added to the armamentarium of rheumatologists over the
last 60 years, the approach to the treatment of rheumatoid arthritis has changed. Many …

Human lymphocyte subpopulations. Effect of corticosteroids.

DT Yu, PJ Clements, HE Paulus… - The Journal of …, 1974 - Am Soc Clin Investig
Normal subjects given 60 mg of prednisone orally at 8:00 am developed a transient lymphopenia
at 2:00 pm To define the populations of lymphocytes affected the number and type of …

Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis

…, M Taylor, M McMahon, HE Paulus… - Annals of the …, 2012 - ard.bmj.com
Objectives Reverse cholesterol transport (RCT) is a major antiatherogenic function of high
density lipoprotein (HDL). In the current work, the authors evaluated whether the RCT …